Home
About Us
Locations
Funding
Prevent Breast Cancer
Milestones
Impact
Patient and Public Participation
Contact
Accessibility
Principal Researchers
Associate Members
Publications
Selected Publications - 2023
Selected Publications - 2022
Selected Publications - 2021
Selected Publications - 2020
Selected Publications - 2019
Selected Publications - 2018
Selected Publications - 2017
Selected Publications - 2016
Events
Public Outreach Event 2020
IPVC Research Open Day
Annual Symposium 2016
Seminars
News
Education
Publications
Selected Publications - 2023
Selected Publications - 2022
Selected Publications - 2021
Selected Publications - 2020
Selected Publications - 2019
Selected Publications - 2018
Selected Publications - 2017
Selected Publications - 2016
Related Links
The University of Manchester
Christie NHS Foundation Trust
Prevent Breast Cancer
Manchester University NHS Foundation Trust (MFT)
MCRC
Breast Cancer Now
Accessibility
Selected Publications from 2023
Publications
RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells
Chen F, Gurler S, Novo D, Selli C, Alferez D, Eroglu S, Pavlou K, Zhang J, Sims A, Humphreys N, Adamson A, Campbell A, Sansom O, Tournier C, Clarke R, Brennan K, Streuli C, Ucar A
DOI: 10.1038/s41388-022-02574-6 Oncogene
2023
42
pages679–692
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).
Evans DG, McWilliams L, Astley S, Brentnall AR, Cuzick J, Dobrashian R, Duffy SW, Gorman LS, Harkness EF, Harrison F, Harvie M, Jerrison A, Machin M, Maxwell AJ, Howell SJ, Wright SJ, Payne K, Qureshi N, Ruane H, Southworth J, Fox L, Bowers S, Hutchinson G, Thorpe E, Ulph F, Woof V, Howell A, French DP.
Br J Cancer
2023
Apr 1:1-9. doi: 10.1038/s41416-023-02250-
Psychological impact of risk-stratified screening as part of the NHS Breast Screening Programme: multi-site non-randomised comparison of BC-Predict versus usual screening (NCT04359420).
French DP, McWilliams L, Bowers S, Woof VG, Harrison F, Ruane H, Hendy A, Evans DG
Br J Cancer
2023
Feb 11. doi: 10.1038/s41416-023-02156-7
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy
Vella V, Lappano R, Bonavita E, Maggiolini M, Clarke RB, Belfiore A and De Francesco EM
Endocrine Reviews
2023
Mar 4; doi: 10.1210/endrev/bnad005
Seminars